Overview
Martin Figeac practices practicing medicine in Lille, France.
Mr. Figeac is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL), Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, and Acute Myeloid Leukemia (AML).
He is actively involved in clinical research, co-authoring 105 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Martin Figeac
Is Martin Figeac a top-rated expert for Primary Mediastinal B-Cell Lymphoma (PMBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Martin Figeac is classified as an Advanced expert for Primary Mediastinal B-Cell Lymphoma (PMBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Martin Figeac participate in research or clinical trials?
Yes. Martin Figeac has published 105 articles and abstracts on conditions like Primary Mediastinal B-Cell Lymphoma (PMBCL). You can view a list of Martin Figeac's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Figeac isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaMr. Figeac isAdvanced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Lactose IntoleranceMr. Figeac isAdvanced. Learn about Lactose Intolerance.
- LeukemiaMr. Figeac isAdvanced. Learn about Leukemia.
- Non-Hodgkin LymphomaMr. Figeac isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Experienced
- Achalasia Microcephaly SyndromeMr. Figeac isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Acute Lymphoblastic Leukemia (ALL)Mr. Figeac isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Childhood Acute Myeloid LeukemiaMr. Figeac isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- ECHO VirusMr. Figeac isExperienced. Learn about ECHO Virus.
- Esophageal AtresiaMr. Figeac isExperienced. Learn about Esophageal Atresia.
- Familial Colorectal CancerMr. Figeac isExperienced. Learn about Familial Colorectal Cancer.
- Lung CancerMr. Figeac isExperienced. Learn about Lung Cancer.
- MalabsorptionMr. Figeac isExperienced. Learn about Malabsorption.
- MelanomaMr. Figeac isExperienced. Learn about Melanoma.
- MesotheliomaMr. Figeac isExperienced. Learn about Mesothelioma.
- MicrocephalyMr. Figeac isExperienced. Learn about Microcephaly.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Figeac isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Ovarian CancerMr. Figeac isExperienced. Learn about Ovarian Cancer.
- PneumoniaMr. Figeac isExperienced. Learn about Pneumonia.
- SclerodermaMr. Figeac isExperienced. Learn about Scleroderma.
- Strep ThroatMr. Figeac isExperienced. Learn about Strep Throat.
- Systemic Sclerosis (SSc)Mr. Figeac isExperienced. Learn about Systemic Sclerosis (SSc).
- T-Cell LymphomaMr. Figeac isExperienced. Learn about T-Cell Lymphoma.
- Viral GastroenteritisMr. Figeac isExperienced. Learn about Viral Gastroenteritis.